Key facts
- It has raised $2.7M.
- Notable investors include University of California, Berkeley SkyDeck, Berkeley, Berkeley SkyDeck Fund.
- Status: Privately Held (backing).
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for AsparaGlue
- ·The full record, as it builds
Funding rounds
No funding rounds for AsparaGlue are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About AsparaGlue
Developer of a synthetic surgical adhesive platform intended to improve sealing and tissue repair in wet surgical environments. The company offers strong mechanical performance, reliable adhesion in wet conditions, biocompatibility, bioresorbability, ease of use, and low production cost, enabling surgeons performing lung procedures to achieve more dependable sealing and improved surgical outcomes.
- Sector
- Healthcare
- HQ
- Berkeley, CA, United States
- Founded
- 2023
- Employees
- 4
- Website
- asparaglue.com/
- Ownership
- Privately Held (backing)
AsparaGlue doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in AsparaGlue shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on AsparaGlue in its N-PORT filings yet. We sweep new filings monthly.